← Current compounder rows

Current NDC auxiliary source row compounder:4795

This page is keyed by dataset, FDA.report source record ID, and physical source row number. Empty values are shown rather than omitted.

Complete normalized row#

Record Source
ndc_compounder_zip
Product Ndc Raw
69194-119
Product Ndc
69194-119
Product Ndc Digits
69194119
Product Type Name
HUMAN COMPOUNDED DRUG
Proprietary Name
119 - NOREPINEPHRINE 16 MG/250ML 10CT
Proprietary Name Suffix
[empty]
Nonproprietary Name
NOREPINEPHRINE 16 MG/250ML
Dosage Form Name
INJECTION
Route Name
INTRAVENOUS
Marketing Category Name
OUTSOURCING FACILITY COMPOUNDED HUMAN DRUG PRODUCT (EXEMPT FROM APPROVAL REQUIREMENTS)
Labeler Name
Pine Pharmaceuticals LLC
Establishment Name
Pine Pharmaceuticals LLC
Establishment Fei
[empty]
Substance Name
NOREPINEPHRINE BITARTRATE
Active Ingredients Info
16 mg/250 mL
History Active Ingredients Raw
NOREPINEPHRINE BITARTRATE
History Active Ingredients Info Raw
16 mg/250 mL
History Dosage Raw
INJECTION
Dea Schedule
[empty]
Package Ndc Raw
69194-119-10
Package Ndc
69194-119-10
Package Ndc Digits
6919411910
Package Ndc11
69194011910
Package Description
10 BAG in 1 CASE (69194-119-10) > 250 mL in 1 BAG (69194-119-01)
Reporting Period Raw
2024-2
Reporting Period
2024-2
Normalization Status
valid
Source Url
https://www.accessdata.fda.gov/cder/compounders_ndc_directory.zip
Source Archive
compounders_ndc_directory.zip
Source File
compounders_ndc_directory.txt
Source Date
2026-09-18
Source Last Modified
Fri, 18 Sep 2026 15:17:23 GMT
Source Archive Sha256
222f6800f79cb1a0fa79431b7226bd6b34899999dbf086af51004a96774ada98
Source Member Sha256
f8d9743e5616579a34d614887e86a53913efa0a63d3138d59d2f87cbb4d0cc17
Source Record Id
compounder:4795
Source Row Number
4795
Source Row Hash
3ba411eec1da71ad3defc82148abb8819a0887f8a699f7522a6925b45e3f62e4
Import Run Id
20261116T204628Z
Loaded At
2026-11-16 20:58:00

Exact raw FDA source fields#

{
    "ROUTENAME": "INTRAVENOUS",
    "PRODUCTNDC": "69194-119",
    "DEASCHEDULE": "",
    "LABELERNAME": "Pine Pharmaceuticals LLC",
    "SUBSTANCENAME": "NOREPINEPHRINE BITARTRATE",
    "DOSAGEFORMNAME": "INJECTION",
    "NDCPACKAGECODE": "69194-119-10",
    "PRODUCTTYPENAME": "HUMAN COMPOUNDED DRUG",
    "PROPRIETARYNAME": "119 - NOREPINEPHRINE 16 MG/250ML 10CT",
    "REPORTINGPERIOD": "2024-2",
    "NONPROPRIETARYNAME": "NOREPINEPHRINE 16 MG/250ML",
    "PACKAGEDESCRIPTION": "10 BAG in 1 CASE (69194-119-10)  > 250 mL in 1 BAG (69194-119-01) ",
    "ACTIVEINGREDIENTSINFO": "16 mg/250 mL",
    "MARKETINGCATEGORYNAME": "OUTSOURCING FACILITY COMPOUNDED HUMAN DRUG PRODUCT (EXEMPT FROM APPROVAL REQUIREMENTS)",
    "PROPRIETARYNAMESUFFIX": ""
}

Normalization notes#

[]

Current status projection#

Dataset
compounder
Record Source
ndc_compounder_zip
Source Record Id
compounder:4795
Source Row Number
4795
Status Scope
package
Lookup Ndc
69194-119-10
Lookup Ndc Digits
6919411910
Product Ndc
69194-119
Product Ndc Digits
69194119
Package Ndc
69194-119-10
Package Ndc Digits
6919411910
Package Ndc11
69194011910
Product Id
[empty]
Status Code
COMPOUNDER
Status Label
Outsourcing facility compounded drug report
Reporting Period Raw
2024-2
Reporting Period
2024-2
Source Table
fda_ndc_aux_compounder
Source File
compounders_ndc_directory.txt
Source Date
2026-09-18
Source Row Hash
3ba411eec1da71ad3defc82148abb8819a0887f8a699f7522a6925b45e3f62e4
Import Run Id
20261116T204628Z
Loaded At
2026-11-16 20:58:00